首页>
外国专利>
BRCA1 mRNA expression levels predict survival in breast cancer patients treated with neoadjuvant chemotherapy
BRCA1 mRNA expression levels predict survival in breast cancer patients treated with neoadjuvant chemotherapy
展开▼
机译:BRCA1 mRNA表达水平预测新辅助化疗治疗的乳腺癌患者的生存
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to methods for predicting the clinical outcome of a patient which suffers from breast cancer based on the expression levels of BRCA1, wherein low BRCA1 expression levels are indicative of a good prognosis. Moreover, the invention relates to methods for predicting the response to a neoadjuvant therapy based on a combination of an anti-metabolite, an intercalating agent and an alkylating agent of a patient which suffers from breast cancer based on the expression levels of BRCA1.
展开▼